BLNDX | MBXCX | BLNDX / MBXCX | |
Total Expense Ratio | 1.26 | 3.03 | 42% |
Annual Report Gross Expense Ratio | 1.39 | 3.03 | 46% |
Fund Existence | 6 years | 10 years | - |
Gain YTD | 1.677 | 3.359 | 50% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 25000 | 2500 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 738M | 8.45B | 9% |
Annual Yield % from dividends | 5.72 | 0.92 | 621% |
Returns for 1 year | 0.96 | 4.25 | 23% |
Returns for 3 years | 14.15 | 5.27 | 268% |
Returns for 5 years | 55.39 | 42.96 | 129% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AFDRX | 56.64 | 0.36 | +0.64% |
American Century Large Cap Equity R | |||
RYCFX | 48.07 | 0.19 | +0.40% |
Rydex Biotechnology C | |||
LRSCX | 14.95 | 0.06 | +0.40% |
Lord Abbett Small Cap Value A | |||
MXEVX | 12.34 | 0.03 | +0.24% |
Empower Core Strategies Intl Eq Inv | |||
DFIEX | 19.49 | -0.02 | -0.10% |
DFA International Core Equity 2 I |